Business

The lawsuit, filed on behalf of purchasers of Veradigm's common stock, alleges the company and its executives overstated the business's historical revenues by at least $20 million.

Providers are responsible for navigating variable coverage schemes while caring for patients, says Jay Rughani, investment partner at Andreessen Horowitz. AI and LLMs advancements can help fix this trajectory and reduce administrative burnout.  

The funds come two years after the company scored a $1.15 billion investment.

The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.

Dr. Don Rucker, chief strategy officer for 1upHealth, discusses TEFCA going live, ONC's Health IT Certification Program, key takeaways from the final HTI-1 and how ONC's certification rule may burden both providers and vendors.   

Brigid Bondoc, partner and life sciences attorney at Morrison Foerster, discusses government priorities pertaining to federal regulation of AI, where complications may arise, and concerns she has heard related to policy decisions.  

The company offers diagnostic tests and therapeutics to detect and treat endometriosis, female fertility and bacterial vaginosis.

President Biden failed to overturn a U.S. International Trade Commission ban on sales and imports of Watch Series 9 and Watch Ultra 2.

Brian Esterly, CEO of TimeDoc Health, discusses health IT's role in bringing together patients and care teams and facilitating self-care management, particularly for patients with chronic conditions in healthcare deserts.  

Jay Rughani, investment partner at a16z, discusses 2023 events, predictions for digital health funding in 2024 and proper AI regulation to avoid stifling innovation.